171 related articles for article (PubMed ID: 3747335)
41. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy.
Wang F; Looi LM; Chua CT
Q J Med; 1982; 51(203):312-28. PubMed ID: 7146313
[TBL] [Abstract][Full Text] [Related]
42. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.
Schulman SL; Kaiser BA; Polinsky MS; Srinivasan R; Baluarte HJ
J Pediatr; 1988 Dec; 113(6):996-1001. PubMed ID: 3193322
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
Katsuno T; Masuda T; Saito S; Kato N; Ishimoto T; Kato S; Kosugi T; Tsuboi N; Kitamura H; Tsuzuki T; Ito Y; Maruyama S
Clin Exp Nephrol; 2019 Feb; 23(2):207-214. PubMed ID: 30121802
[TBL] [Abstract][Full Text] [Related]
44. Minimal-change glomerulopathy of adulthood.
Korbet SM; Schwartz MM; Lewis EJ
Am J Nephrol; 1988; 8(4):291-7. PubMed ID: 3189423
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
[TBL] [Abstract][Full Text] [Related]
46. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
[TBL] [Abstract][Full Text] [Related]
47. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
[TBL] [Abstract][Full Text] [Related]
48. Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults.
Koike K; Tsuboi N; Utsunomiya Y; Kawamura T; Hosoya T
Am J Nephrol; 2011; 34(6):542-8. PubMed ID: 22123493
[TBL] [Abstract][Full Text] [Related]
49. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
Makino H; Haramoto T; Shikata K; Ogura T; Ota Z
Am J Nephrol; 1995; 15(5):439-41. PubMed ID: 7503146
[TBL] [Abstract][Full Text] [Related]
50. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
Al-Khader AA; Lien JW; Aber GM
Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
[TBL] [Abstract][Full Text] [Related]
51. [Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital].
Mori D; Shinzawa M; Namba T; Yamaguchi Y; Itano S; Imakita N; Matsuda J; Murata H; Takeji M; Yamamoto R; Isaka Y; Yamauchi A
Nihon Jinzo Gakkai Shi; 2012; 54(7):1023-30. PubMed ID: 23234214
[TBL] [Abstract][Full Text] [Related]
52. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
Dundon S; O'Callaghan U; Raftery J
Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
[No Abstract] [Full Text] [Related]
53. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
Huisman RM; de Jong PE; de Zeeuw D; van Imhoff GW; van der Hem GK
Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
[TBL] [Abstract][Full Text] [Related]
54. Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis.
Cameron MA; Peri U; Rogers TE; Moe OW
Nephrol Dial Transplant; 2004 Oct; 19(10):2642-6. PubMed ID: 15388821
[TBL] [Abstract][Full Text] [Related]
55. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
Forese S; Tamborino G; Genova R
Minerva Pediatr; 1977 Mar; 29(8):547-50. PubMed ID: 865435
[No Abstract] [Full Text] [Related]
56. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
57. Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.
Stefan G; Busuioc R; Stancu S; Hoinoiu M; Zugravu A; Petre N; Mircescu G
Clin Exp Nephrol; 2021 Mar; 25(3):240-250. PubMed ID: 33090339
[TBL] [Abstract][Full Text] [Related]
58. Minimal-change nephrotic syndrome in adults treated with alternate-day steroids.
Nair RB; Date A; Kirubakaran MG; Shastry JC
Nephron; 1987; 47(3):209-10. PubMed ID: 3683690
[TBL] [Abstract][Full Text] [Related]
59. Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study.
Komukai D; Hasegawa T; Kaneshima N; Takayasu M; Sato Y; Hirose M; Yoshimura A
Nephrology (Carlton); 2016 Oct; 21(10):887-92. PubMed ID: 26603689
[TBL] [Abstract][Full Text] [Related]
60. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
Brodehl J; Krohn HP; Ehrich JH
Klin Padiatr; 1982; 194(3):162-5. PubMed ID: 6752557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
